ARTICLE | Politics, Policy & Law
Woodcock to serve as acting FDA commissioner, Sharfstein a contender for top FDA job
Kessler will advise Biden on COVID-19, will not return to FDA
January 13, 2021 10:31 PM UTC
David Kessler is out of the running for nomination as FDA commissioner, leaving Joshua Sharfstein as a front-runner to lead FDA, sources briefed by the Biden transition team told BioCentury. While the list of candidates had narrowed to Kessler and Sharfstein, the delay in naming a candidate for the position could be a sign that other names are being considered.
Janet Woodcock is expected to be named acting FDA commissioner, according to the sources, who spoke on condition of anonymity. ...
BCIQ Company Profiles